FindMyKOL

Matteo Lambertini, MD

Enriched profile

Director of Medical Oncology, Galliera Hospital (Genoa) · Ente Ospedaliero Ospedali Galliera

ORCID↗NPINone on file
✓ Itemized profile
RegionNot on fileSpecialtyMedical OncologyFocusBreast Cancer Treatment Studies+4
Active KOLLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH fundingNone on fileWhy? →

Matteo Lambertini is Director of Medical Oncology, Galliera Hospital (Genoa) at Ente Ospedaliero Ospedali Galliera. OpenAlex indexes 737 publications with 17,842 citations (h-index 67); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 9 Nov 2026

Overview

Updated 10 Nov 2026

Matteo Lambertini is Director of Medical Oncology, Galliera Hospital (Genoa) at Ente Ospedaliero Ospedali Galliera. The public record shows 737 publications with 17,842 citations (h-index 67), centered on Breast Cancer Treatment Studies, BRCA gene mutations in cancer, Reproductive Biology and Fertility. It also documents an investigator role on 5 registered clinical trials.

  • Most recent indexed publication: 2026 · European journal of clinical investigation
  • Top research focus: Breast Cancer Treatment Studies
  • 5 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 10 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer5 trialsColorectal CancerCOVID-19Gastroesophageal CancerNeuro-Oncology / GliomaHead & Neck CancerHepatobiliary CancerHIVIdiopathic Pulmonary FibrosisLeukemia (AML/ALL/CML/CLL)MelanomaLung Cancer (NSCLC/SCLC)ObesityOvarian / Gynecologic CancerPancreatic CancerSarcomaViral Hepatitis (B/C)

Research focus

OpenAlex concept fingerprint
Breast Cancer Treatment StudiesBRCA gene mutations in cancerReproductive Biology and FertilityAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer Research

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials1Industry payments—Erasme University HospitalClinical trials1Industry payments—Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoClinical trials1Industry payments—IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyClinical trials1Industry payments—Jules Bordet InstituteClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
737publications

Publications indexed by OpenAlex, matched via ORCID. 111 in PubMed. Counts exclude supporting files.

17,842citations

Citations across these publications.

67h-index

H-index from these publications. i10-index 264.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

Updated 9 Nov 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 9 Nov 2026

140 congress contributions (2013–2026) across AACR, ASCO, ASH, ESHRE Annual Meeting, ESMO, ESTRO Congress, SABCS per OpenAlex. The most recent:

Publications

Updated 9 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Congress posts on X

Post links from an X account tied to this person through reviewed identity evidence.

  1. Listed under ESMO 2026

    Collection sources

    Collected .

  2. Listed under ESMO 2026

    Collection sources

    Collected .

  3. Listed under ESMO 2026

    Collection sources

    Collected .

Explore all 16 stored posts

These links cover selected congress pages. They do not establish attendance or a complete posting history. Post availability may change.

Online presence

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • X / Twitter

    x.com/matteolambe

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 9 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    PhD

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youngsurvival.org ↗

Editorial & leadership roles

journal and society appointments

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.